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Summary 
Clinical deficiency of micronutrients is uncommon in the developed world, but 
interest has increasingly focused on non-clinical deficiencies, or suboptimal status of 
micronutrients and the effect such deficiencies may have on risk of chronic disease. 
The focus on folate has greatly evolved over the past two decades from the 
prevention of anaemia to the prevention of neural tube defects (NTD). Folate also 
appears to have a lot of other health benefits; accumulating evidence suggests that 
folate may play a role in the prevention of cardiovascular disease and cancer. This 
expanding role of folate in prevention has major public health implications 
Public health policies have developed in two ways: some American and developing 
countries have chosen mandatory fortification of staple foods with folic acid (FA), 
while most western European countries so far have decided not to do so. In most 
Western European countries, voluntary fortification is nevertheless allowed, and 
some specific products are available. 
In this thesis the main aim was to: “determine a level of mandatory fortification that 
maximised folic acid (FA) intake for women of fertile age, to assist in achieving their 
recommended intake of 400 μg FA/day, whilst preventing a significant proportion of 
people in the target and non-target groups to exceed the upper safe levels of intake. In 
considering mandatory fortification of food with FA, flour and bread were selected as 
the food vehicles. Breakfast cereals, juice, nectar, yoghurt and milk were selected as 
possible products for voluntary fortification. The effect of various fortification and 
supplementation scenarios have been studied for children 4, 9 and 13 years old, adult 
men, women of child-bearing age and pregnant women from. Norkost II (1997), 
Ungkost II (2000-2001) and the Norwegian Mother and Child Cohort Study. 
According to the results it is impossible with mandatory fortification of food with FA 
in Norway at a level that ensures the majority of women in the target group will 
consume 400 μg folate/day, without other population groups exceeding upper safe 
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level for FA. If mandatory fortification of flour with FA would be 140 µg FA/100 g 
flour, 41% of the fertile women and 29% of the pregnant women would reach the 
recommended intake. In the same scenario almost 20% of the children aged 4 and 9 
years would exceed upper level. The scenario where least persons got an intake over 
upper level was when bread was fortified with 100 μg FA/100 g. In this scenario 19% 
of the children aged 4 years and 15% aged 9 years reaches upper level, whereas over 
50% of the fertile and pregnant women did not reach the recommended intake. 
With intake of voluntary fortified foods 83% of the fertile women and pregnant 
women would reach the recommendations, if taking FA supplement with 200 μg/day 
in addition to dietary folate. In the fortification scenarios for those taking 
supplements with 200 μg FA in addition to the five voluntary products and dietary 
folate show that 99% of children aged 4 years and 75% aged 13 years received total 
folate over UL. The fact that some of the supplements designed for children contain 
200 μg FA should be questioned, especial if Norway goes for mandatory fortification 
but also with regards to voluntary fortification. It might be a good decision to limit 
the content of FA in supplements designed for children.  
Data on the long term effects of increased folate intake are limited. The effects of 
long term exposure to high concentrations of FA are unknown, but antimetabolite 
effects are theoretically possible. We need to know more about the effects of chronic 
exposure to FA before instituting mandatory fortification. The strategy of universal 
fortification of staple foodstuffs with folic acid also presents the possibility of life-
long exposure to unmetabolized FA. Therefore Norway should wait for new 
knowledge before starting mandatory fortification 
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1. Bakground 
Folate plays a central part in metabolism and in the maintenance of tissue function. 
An adequate intake therefore is necessary, but provision of excess supplements to 
people who do not need them may be harmful. 
1.1 Folate 
Folate was isolated in 1941 from spinach and named after the Latin word folium as 
means leaf. The initial reason for research on folate metabolism, was to find a cure 
for anaemia, it was soon recognized that the administration of folate enhanced the 
growth of existing tumours and that folate metabolism may be a promising target for 
anticancer drug design (1). 
1.1.1 Function 
Natural reduced folates are important vitamins that are essential for the eukaryotic 
cell and cannot be synthesized in the human body. Many different plants and bacteria 
serve as folate resources. Folate is a generic term for a naturally occurring family of 
B-group vitamins comprising an aromatic pteridine ring linked to p-aminobenzoic 
acid and a glutamate residue. Folic acid (FA), the fully oxidized monoglutamyl form, 
pteroyl monoglutamic acid (PGA) is the synthetic form used commercially in 
supplements and in fortified foods. 
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Fig.1 Folic Acid 
As one-carbon donors and co-factors they play a role in a variety of biosynthetic 
reactions. As an essential cofactor for the de novo biosynthesis of purines and 
thymidylate, folate plays an important role in DNA synthesis, stability and integrity, 
and repair. Folates also regulate gene expression by providing methyl donors for 
DNA methylation (2), and in the remethylation of homocysteine (Hcy) to methionine, 
which is the precursor of S-adenosylmethionine (SAM), the primary methyl group 
donor for most biological methylations, including that of DNA (3). 
Food folates must be hydrolysed by pancreatic and brush border folate conjugate to 
monoglutamates prior to absorption in the upper part of the small intestine (4), and 
then metabolized upon absorption, in the gut mucosa and liver, to 5-methyl 
tetrahydrofolate (5-MTHF), which is usually the only form found in plasma. In 
plasma the amino acid homocysteine concentration is a sensitive marker of folate and 
vitamin B12 status (5). Methylenetetrahydrofolate reductase (MTHFR) is a key 
regulatory enzyme in the metabolism of folate. The common C677T variant in the 
MTHFR gene results in a reduced activity of this enzyme, thereby increasing the 
availability of folate for the production of thymidylate and purine for DNA synthesis 
and repair (6). 
Erythrocyte folate is considered to be the best indicator of long-term status since the 
lifespan of the erythrocyte is 120 days, and folate is retained in the erythrocyte for the 
duration of its life. Folate is incorporated into the developing erythroblast during 
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erythropoiesis in the marrow and less than 1% of circulating erythrocytes are replaced 
daily (4). Unlike serum folate, erythrocyte folate is not affected by recent or transient 
changes in intake, which may reflect actual intake (7). Macrocytic anaemia is one of 
the clinical manifestations of folate deficiency. 
1.1.2 Sources 
Folates are found in a wide variety of foods. Rich sources are liver, yeast extract, and 
green leafy vegetables such as Spinach, Kale, and Brussels sprouts (8). But cereal 
products, vegetables, fruits and potatoes appear to be the most significant sources of 
folate in the Norwegian diet. The Norwegian survey Norkost (n=2672) demonstrated 
that cereals and cereal products are the predominant sources of folate in the 
Norwegian population, providing approximately 27% of the daily intake of folate for 
women and 32% for men. 
1.1.3 Bioavailability 
Food folate bioavailability and the factors that affect it are poorly understood (9). A 
number of methodological approaches have been used to address food folate 
bioavailability, but there are some major limitations that may confound the 
interpretation of studies using these various approaches. Chronic bioavailability 
studies explore, usually in parallel design, the effect of long-term, typically 4–24 
weeks, interventions with comparable doses of FA and reduced folates on markers of 
folate status. According to McNulty this type of studies with food folates are likely to 
give the most meaningful results in future research, but only if they are based on 
robust and tightly controlled protocols to ensure the delivery of food folate and FA at 
equivalent doses throughout the intervention period (9). Little is also known about 
the extent to which variation in the bioavailability of folate in foods would affect 
human nutritional status and health, but such associations undoubtedly exist, a variety 
of factors can contribute to incomplete bioavailability of naturally occurring folates 
from foods (10). Example of that is: folate status, alcohol (a well-known folate 
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antagonist), cigarette smoking (which depletes systemic and intracellular folate), and 
the supply of other methyl group donors (e.g., vitamins B6 and B12 and methionine) 
involved in one-carbon transfer (11). 
Folic acid in fortified food has been found to be highly bio available (12). Whereas 
bioavailability of folate from diet is set to 50% (13). That is built on estimate of an 
old study by Sauberlich et al. from 1987, with a small number of subjects, and not all 
food sources of folate exhibit poor bioavailability. It has been suggested that an 
assortment of fruit and vegetables will provide dietary folate with 60–90% 
bioavailability relative to folic acid (14). Other evidence has shown that FA added to 
food has about 85% of the bioavailability of free FA (15). 
Differentiation between folate forms is important since the individual folate 
derivatives show different stability and bioavailability. Many aspects of current folate 
requirements are being expressed in terms of dietary folate equivalents, in which an 
adjustment is employed to account for differences in mean bioavailability of natural 
and added forms of folate (10). It is nowadays common to use “Dietary Folate 
Equivalents” (DFE), which account for differences in the absorption of naturally 
occurring food folate and the more bioavailable synthetic folic acid. DFE may be 
expressed in different ways, depending on the type of conversion needed. 
1 μg DFE = 1 μg Food folate = 0,6 μg Folic acid ,if it is added to food, and 0,5 μg if it 
is taken without food (16). 
1 μg Folic acid = 1,7 μg DFE 
1.1.4 Recommendation 
Folate exists in many different chemical forms in foods and differences in its stability 
have led to difficulties in characterising the vitamin and establishing accurate data on 
food folate content. The most frequently used folate quantification methods are 
microbiological assays, protein-binding assays (PBA) and high performance liquid 
chromatography (HPLC). However, there is today no method with a status as 
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reference method for the measurement of natural folate in foods since all methods are 
complicated by difficulties in sample preparation, including extraction, deconjugation 
and purification (17). 
In the Nordic Nutrition Recommendation (NNR) 1996, the recommended intake of 
folate was increased from 200 to 300 μg /day in order to provide a greater margin of 
safety and allow possibilities to increase store, especially in fertile women. Today the 
recommended daily intake of dietary folate in Norway is 300 μg for adults but 400 μg 
for fertile women (13). In NNR 1996, an intake of 400 μg/day was recommended 
from the beginning of the pregnancy. A daily intake of 400 is now recommended for 
all women capable of becoming pregnant. Pregnant and lactating women are now 
recommended a daily intake of 500 μg (13). Both FAO/WHO and the US authorities 
recommend all adults a daily intake of 400 μg, pregnant women 600 μg and lactating 
women 500 μg. 
Table 1. NNR recommended daily intake of Folate 
Recommended Folate intake μg/day 
Children 2-5 years 80 
Children 6-9 years 130 
Children 10-13years 200 
Adults 300 
Women of fertile age 400 
Pregnant and lactating women 500 
 
There is no evidence for risk associated with high intake of folates from natural 
sources. The safety of chronic very high intakes of folic acid is on the other hand 
largely unknown. The Institute of Medicine recommends a tolerable upper intake 
level for folic acid from supplements or fortified foods of 1000 μg/day for adults. 
These upper intake levels were developed primarily to avoid masking the anaemia 
and missing the neuropathy of vitamin B12 deficiency because very few data were 
available on other possible adverse effects of chronic high intakes. The clinical 
significance of the upper intake levels is not well established and they were instituted 
as a first attempt to raise awareness that not all levels may be safe. The European 
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Union Scientific Committee on Foods (2000) defines the upper level (UL) as: “the 
maximum level of total chronic daily intake of a nutrient (from all sources, including 
foods, water, nutrient supplements and medicines) judged to be unlikely to pose a risk 
of adverse health effects to almost all individuals in the general population.” 
Individuals at greatest risk of exceeding the UL are those who consume large 
amounts of food, choose proportionally more fortified foods or take dietary 
supplements. The proportion of individuals at risk of excessive intakes can be 
estimated by comparing the 97.5 percentile intakes against the UL. 
Oral folic acid, in excess of about 260 μg, can lead to the appearance of 
unmetabolised FA in the systemic circulation (18). The long term biological effects 
of this exposure are unknown (19). Although small doses of oral folic acid are 
efficiently metabolized to 5-MTHF before entering the portal blood, intakes > 200 μg 
appear to overload this metabolic capacity, leading to the appearance of 
unmetabolised FA in plasma. 
A follow up placebo controlled double-blind randomized trial addressed the question 
of what level of FA per day would be required to increase a woman’s red cell folate 
concentration to a protective level (20). That study demonstrated that 200 μg of FA 
per day might reduce neural tube defects by 39–41% and would be safer for the 
general population than 400 μg/day, which would be very effective but could result in 
unnecessarily high exposure for many people. 100 μg FA/day was predicted to result 
in a reduction of 22–26% in NTD over time (20). 
Table 2. NNR: upper intake levels of Folic Acid μg per day 
Upper intke levels of Folic Acid μg/day 
Children 1-3years 200 
Children 4-6years 300 
Children 7-10 years 400 
Adolecent 11-14 years 600 
Adolecent 15-17 years 80 
Adults 1000 
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1.2 Intake in Norway 
There are several problems involved in determining and interpreting folate intake. 
The quantity of folate in food must be known in order to interpret the relationships 
among food selection, folate intake, folate bioavailability and nutritional status. 
1.2.1 Food folate 
The average intake in the Nordic countries is estimated to 240-340 μg/10MJ (13). 
According to Norkost II a nation-wide survey of a representative random sample of 
the adult Norwegian population (n=2672) in 1997, the average intake of food folate 
was 309 μg for men, and 250 μg for women(21). In Ungkost, 2000-2001, the average 
intake of food folate was 196 μg for children aged 9 years (n=810) and 205 μg for 
those aged 13 (n=1005) (22). Data from 19711 women in the Norwegian Mother and 
Child Cohort Study (MoBa), in 2000-2001, found food folate intake of 272 μg for 
pregnant women. 
According to NNR-04 a balanced diet following general dietary advice and 
recommended energy distribution will contain approximately 400 μg/10 MJ. 
1.2.2 Supplement 
In Norway, official guidelines from 1998 state that all women who may become 
pregnant should take a daily FA supplement of 400 μg from one month before 
pregnancy throughout the first 2–3 months of pregnancy, to reduce the risk of NTD. 
According to Norkost in 1997 only 49% of the women and 29% of the men used a 
supplement containing FA. In 2001 Braekke and Staff evaluated the use of FA 
supplementation in approximately 1500 pregnant women in Oslo. Folic acid was 
found to have been used by 58% at any time during their pregnancy at the 
recommended dose of 400 μg folic acid (73% of the non-immigrant women and 19% 
of the non-western immigrant population). The majority of women did not take folic 
acid periconceptionally as recommended by health authorities. Only 2.3% of the 
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immigrant women vs. 21.8% of the non-immigrant women had used FA in the 
recommended way (23). 
Data from 22 500 women in the MoBa with deliveries recorded in 2000–2003 have 
been analyzed. Of the women in the study had 72% had used supplements containing 
FA at some point before or during pregnancy but that only 10% had taken FA 
supplements regularly in the recommended way. They also saw that maternal 
education and marital status were strong predictors of using supplements (24). 
1.3 Health benefits 
The evidence that folate deficiency plays an important part in the pathogenesis of 
neural tube defect (NTD) is now beyond doubt. But folate don’t only reduce NTD, it 
also has a lot of other health benefits. 
1.3.1 Anomalies of the central nervous system 
The original suggestion that folate deficiency, apart from causing megaloblastic 
anaemia, might also play a part in producing NTD was made by Brian Hibbard 
(1964), who demonstrated an association between folate deficiency and NTD. This 
was supported by others, as Smithells et al.(25). 
Neural tube defects are the largest group of anomalies of the central nervous system 
and are a major cause of morbidity and mortality in infants, worldwide. It has a 
multifactorial aetiology incorporating a combination of genetic and environmental 
factors, such as nutrition. Many NTD can be prevented by taking 400 μg of folic acid 
or probably even less during the periconceptional period (20). The well documented 
reduction in neural tube defect risk induced by FA has prompted widespread health 
advisories promoting daily supplementation among all women of childbearing age. It 
is now generally accepted that between 50 and 70% of affected births are preventable 
by maternal ingestion of FA before and during early pregnancy. The evidence for this 
 19
is based on a substantial number of international trials and case-control studies during 
the past 20 years (1;20;26-31). 
According to the special report from EUROCAT in 2003, there are 36 congenital 
birth-defect registries in Europe, scattered among 17 countries. The number of 
pregnancies affected by NTDs each year has been estimated to be 4000 in Europe. 
There is a higher prevalence in women of low socioeconomic status (25;32) and there 
is a variation in rates as related to ethnic and racial background (26). There is also 
geographic variation across Europe in the prevalence of NTD, with the United 
Kingdom and Ireland having the highest rates for several decades (32), as it is 
worldwide (26). The prevalence of NTDs has declined in many countries, in part 
because of prenatal diagnosis and selective termination of affected pregnancies, when 
allowed by the country. In Norway NTD are affecting approximately 70 pregnancies 
every year (33). According to data from Medical Birth Registry of Norway there 
hasn’t been any reduction in the prevalence of NTD attributable to the 
recommendation to take folate (33). 
The research first suggesting an association between NTDs and maternal deficiency 
or defective metabolism of folates was published in 1965. Epidemiologic studies that 
followed supported the hypothesis that FA supplementation reduced the occurrence 
of NTDs. The first conclusive randomized controlled trial, British Medical Research 
Council study (MRC), showed that women who had already had a pregnancy affected 
by an NTD could often prevent more than two thirds of recurrent cases by taking 
4000 μg of FA daily (31). 
Folic acid supplementation appears to correct a disturbance in folate metabolism 
rather than a shortage of dietary folate. While it is accepted that maternal folate 
deficiency is not the underlying cause of NTDs, lower plasma and red cell folate 
concentrations have been noted in mothers carrying affected foetuses and the risk of 
having an affected child was shown to be inversely proportional to maternal early 
pregnancy red cell folate concentration (30). 
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Reports have also suggested that multivitamin supplementation, with FA, reduces the 
risks of other specific congenital malformations. Several lines of evidence support an 
association between maternal use of a vitamin supplement with FA in early 
pregnancy and a reduced risk for offspring with orofacial clefts (34;35). They don’t 
only show reductions in the occurrence of clefts in infants whose mothers took 
vitamin supplements containing FA. They have also shown that mothers’ use of folic 
acid antagonist medications has been associated with an increased risk of delivering 
offspring with oral clefts (36). It is not clear if the same doses (400 μg) that reduce 
NTD will reduce the risk for oral clefts. In fact, as the use of fortified cereal and 
vitamin supplements has increased in Dublin, birth prevalence of NTDs has 
decreased dramatically while the birth prevalence of oral clefts has barely changed. A 
recent Norwegian report, based case-control study, shows that supplementation with 
FA in the periconceptional period reduces the risk of cleft lip, with or without cleft 
palate, in newborns (37). They didn’t see any decreasing in cleft plate alone. It is 
possible that the dose of folic acid needed to prevent cleft palate is higher than the 
dose needed to prevent NTDs (35). 
There is also increasing evidence that multivitamins with folic acid may reduce the 
risk of other congenital malformations such as cardiovascular defects (38;39), urinary 
tract defects (34;38), and limb-reduction defects (39;40). Exactly which nutrients 
should be taken is not clear, and it seems that multivitamin supplements containing 
400 μg of FA may offer greater benefit than FA supplements alone (34). 
1.3.2 Coronary Heart Disease 
The association of homocysteine (Hcy) with Coronary Heart Disease (CHD) has 
generated much interest. Observational studies have consistently demonstrated that 
higher plasma Hcy level is associated with an increased CHD risk (41). Numerous 
studies of folate, Hcy and CHD have associated an increased intake of folate, and a 
reduced concentration of Hcy, with a reduced risk of CHD (42;43), and this 
association has been confirmed by meta-analysis (44;45). Randomized controlled 
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trials have shown that a moderate increase in folate consumption can substantially 
decrease Hcy levels (46).  
Nevertheless, it is unclear whether a long treatment will benefit end points as 
myocardial and death. However, several intervention studies with FA 
supplementation are in progress to establish its effect on cardiovascular mortality and 
morbidity (47). Recently, two intervention trials involving large numbers of patients 
have been published. The Norwegian vitamin trial (NORVIT) looked at various 
combinations of B vitamins, or placebo in 3749 patients who had had an acute 
myocardial infarction. After a median of 40 months, there was a 27% reduction in 
Hcy in those treated with folate and B12, but no effect on myocardial events was 
seen. Contrary to expectations, there was a trend toward an increased rate of events 
among patients receiving B vitamins, in particular the combination of FA, vitamin 
B6, and vitamin B12 (48). In the Heart Outcomes Prevention Evaluation (HOPE)-2 
study, 5522 patients with vascular disease or diabetes were studied over five years. 
They got a daily treatment either with the combination of 2.5 mg of FA, 50 mg of 
vitamin B6, and 1 mg of vitamin B12 or with placebo. Despite a reduction in Hcy, 
again vitamin treatment had no effect on myocardial events, but had a marginally 
significant effect on stroke (49). 
Homocysteine–CHD associations may be confounded in a variety of ways. In some 
studies homocysteine levels are higher in smokers or people from less favourable 
socioeconomic backgrounds, and existing atherosclerosis could itself increase 
homocysteine levels, which would automatically lead to a positive association 
between Hcy and subsequent CHD (50;51). 
1.3.3 Cancer 
It is clear that all areas of research related to folate and disease have expanded, but 
interest in folate in relation to cancer has increased in particular (19). Epidemiologic 
studies over the past decade have suggested an inverse association of folate status 
with cancer. This has been assessed by dietary folate intake or by the measurement of 
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blood folate levels. The studies have observed the risk of cancer of: lungs, 
oropharynx, esophagus, stomach, colorectum, pancreas, cervix, ovary, prostate, brain 
and breast, and the risk of neuroblastoma and leukaemia (52;53). Among these, 
epidemiologic support for such a relationship is clearly most compelling for 
colorectal cancer (54). In a recent large, prospective population-based study of 
Swedish women and men, they report an inverse association between intake of folate 
from foods and the risk of pancreatic cancer (55). The association with dietary folate 
was independent of other known and potential risk factors for pancreatic cancer, 
including age, smoking, obesity, physical activity, and history of diabetes, and it 
persisted after controlling for consumption of fruits and vegetables, many of which 
are naturally high in folate. This findings are consistent with other larges studies 
(56;57). 
Folate has consequently been of particular interest as a potential cancer protective 
agent because of the important roles it plays in nucleotide synthesis, as well as in the 
biological methylation of molecules such as DNA, RNA, proteins, and the 
phospholipids. Folate deficiency is associated with increased risk for several types of 
cancer, through disruption of DNA methylation, DNA synthesis and deficient DNA 
repair (58).  
French et al have presented data showing that the incidence of neuroblastoma in 
Ontario, Canada, seems to have declined dramatically since the start of FA 
fortification of grains in Canada. Neuroblastoma is a cancer of early childhood and 
because it develops in utero, neuroblastoma also remains the most commonly 
diagnosed malignant tumour of infancy. The aggressive nature of this tumour makes 
this disease the most common cause of cancer-related death among children 1 to 4 
years old (59). Another case–control study with Australian children demonstrated that 
folate supplementation during pregnancy reduced the risk of acute lymphoblastic 
leukemia, and that the protective effect of the MTHFR polymorphisms depended on 
adequate folate intake (60). Folate deficiency has been associated with uracil miss 
incorporation into DNA, leading to double strand DNA breaks during uracil excision 
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repair and increasing the risk of chromosomal aberrations that is presumably the 
onset of the leukemogenic process (61). 
Furthermore, the value of folate supplementation during pregnancy was shown to 
prevent acute leukaemia in children. Krajinovic et al reported a reduced risk 
associated with a combination of genotypes. On stratification of patients into those 
born before and after January 1996, when the effects of recommended folate 
supplementation during pregnancy could be observed, Krajinovic et al observed that 
the protective effect was present only in children born before 1996. These results 
suggested that the associated risk with a combination of genotypes in the MTHFR 
gene was dependent on dietary folate status (62). 
1.3.4 Neurological disorders 
B vitamins are required for wellbeing and normal functioning of the brain. Adequate 
intake of folate and vitamins B12 and B6 are already known to be important for the 
prevention of haematological and irreversible neurological abnormalities (63). The 
relationship between B vitamin status and cognitive function has been of interest for 
many years. There is evidence of relationships between intake and status of folate and 
vitamin B12 with neurological, cognitive, and memory impairment (5), but results 
have so far been inconsistent (64). 
Plasma total homocystein (tHcy) is a strong and independent risk factor for memory 
impairment, with a clear dose response relation (65), an elevated plasma level of Hcy 
is also a strong risk factor for Alzheimer’s. A positive relation has been reported 
between various cognitive tests and intake or blood concentrations of B vitamins 
(63;66). Recently Ravaglia concluded that elevated plasma tHcy concentrations and 
low serum folate concentrations are independent predictors of the development of 
dementia and Alzheimer’s (67). Campbell confirm that erythrocyte folate is related to 
dementia after controlling for age, gender, education, income, diabetes diagnosis, 
serum creatinine, and depressive symptoms. But it still needs more randomized 
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clinical trials with tHcy-reducing therapy to provide further evidence for a relation 
among tHcy, B vitamins, and cognition. 
1.3.5 Other health benefits 
As mentioned earlier chronic deficiency of folate in the diet can cause anaemia. Low 
concentrations of serum folate and vitamin B12 and elevated concentrations of 
plasma tHcy have also been associated with psychiatric disorders (68). Low serum 
folate has been associated with reduced bone mineral density in women, and 
responsible for the association between homocysteine and risk of osteoporotic 
fracture in elderly persons (69-71). Folic acid supplementation has also been shown 
to protect patients with rheumatoid arthritis from methotrexate related toxicity 
without jeopardizing the efficacy of methotrexate (72;73). 
1.4 Health risk 
Data on the long term effects of increased folate intake are limited. The effects of 
long term exposure to high concentrations of FA are unknown, but antimetabolite 
effects are theoretically possible (19). Neurological complications may be found in 
patients with vitamin B12 deficiency (74). This may not be the only possible risk of 
folate supplementation. For example, animal and some clinical studies have 
suggested that folate supplementation in higher doses may increase cancer risk and 
accelerate tumour progression (75). Moreover, an association between folate 
deficiency and spontaneous miscarriage has been identified (76). 
1.4.1 Cobalamin deficiency 
High intakes of FA may raise the possibility of masking cobalamin deficiency, 
especially in an elderly population (29;74). There is a metabolic interaction between 
vitamin B12 and FA. Folic acid supplementation can therefore correct anaemia 
associated with vitamin B12 deficiency but will not correct changes in the nervous 
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system that result from this deficiency. Permanent neurological damage may occur if 
vitamin B12 deficiency is left untreated. Before the role of vitamin B12 in causing 
megaloblastic anaemia was appreciated, vitamin B12 deficient patients were often 
treated with FA. In many cases the anaemia improved initially; however, the 
associated neurological damage progressed. This phenomenon has never been studied 
systematically for the obvious reason that patients would never knowingly be given 
the wrong treatment, particularly when the neurological damage associated with 
vitamin B12 deficiency is often irreversible (29). 
Masking of vitamin B12 deficiency, i.e. deficiency without anaemia because of FA, 
does not appear to be increasing as a result of food fortification with folic acid, 
despite the current high exposures. Diagnosing vitamin B12 deficiency in the absence 
of anaemia can be very difficult because it depends on the recognition of sometimes 
subtle neurologic abnormalities. Therefore, it is encouraging that the proportion of 
patients with low vitamin B12 concentrations but without anaemia has not increased 
since fortification of grain with folic acid began in US (77). 
It should be mentioned that the theoretical risk of masking anaemia caused by 
vitamin B12 deficiency has never been reported for a high intake of natural food 
folates and has been described among a small number of patients receiving high 
pharmacological doses of FA (ranging from 5 to 15 mg/day) only (78). In fact, our 
knowledge of how frequently masking occurs is limited, and no evidence of an 
increase in low vitamin B12 concentrations without anaemia after fortification has 
been observed in the United States, although the actual intake is considerably higher 
than expected and exceeds the limit of 1 mg/day for many people (77;79). 
1.4.2 Cancer 
While observational studies show lower cancer rates associated with increased folate 
intake, some case reports and animal experiments suggest opposite effects. Data from 
studies conducted in animal models of colorectal cancer have suggested that 
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exceptionally large doses of FA provided after microscopic neoplasia are established 
may promote rather than suppress carcinogenesis (80). 
Charles et al. followed up a large trial of folate supplementation in pregnancy from 
the 1960s. They examined the association between folate status and death, and they 
also analyzed the effects of folate supplementation. Women taking high doses of 
folate throughout pregnancy may be more likely to die from breast cancer in later life 
than women taking no folate (81). In the study, increased risk was seen at 5 mg of 
folic acid daily, a high dosage recommended only in secondary prevention of NTDs. 
The report has been criticized for its small size, lack of biological plausibility, and for 
causing unfounded alarm in the general population (82). 
In a recent prospective case-control study of 254 prostate cancer cases and 514 
matched controls, it was made a similar observation (83). A statistically significant 
positive association was found between plasma folate and vitamin B12 levels and risk 
of prostate cancer. 
The studies by Kim have shown that the dose and timing of folate intervention are 
critical in providing safe and effective chemoprevention; exceptionally high 
supplemental folate levels and folate intervention after microscopic neoplasia 
established in the colorectal mucosa promote rather than suppress colorectal 
carcinogenesis. Folate deficiency has an inhibitory effect, whereas folate 
supplementation has a promoting effect on the progression of established neoplasm. 
In contrast, folate deficiency in normal epithelial tissues appears to predispose them 
to neoplastic transformation, and modest levels of folate supplementation suppress, 
whereas supraphysiological doses enhance the development of tumours in normal 
tissues (75;80). And as he say, the implication of this issue is important because the 
optimal dose of folate supplementation must be determined for folate 
chemoprevention to be effective and safe in humans. Even if some similarities do 
exist, tumour development in chemical rodent models of colorectal cancer differs in 
several important histological, clinical, and molecular genetic aspects from that 
observed in humans.  
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Preliminary results from the first randomized controlled trial of FA for 
chemoprevention of colorectal polyps have been recently reported at AACR 
(American Association for Cancer Research) 96th annual meeting. More than 1000 
participants with a recent history of colorectal adenomas were randomly assigned to 1 
mg FA daily, with or without aspirin. Follow-up colonoscopies were scheduled 3 
years after the initial endoscopy and supplementation continued until a second 
surveillance exam. In this trial, FA use did not prevent the recurrence of colorectal 
adenomas (84). 
1.4.3 Miscarriage 
Published reports on the relation between FA supplementation during pregnancy and 
risk for miscarriage have been inconsistent. Several studies have reported that folate 
deficiency and defects in folic acid and homocysteine metabolism are associated with 
an increased risk for pregnancy loss (85). By contrast, analyses of data of two 
randomized trials from the beginnings of 1990th, the MRC study from United 
Kingdom and data from Hungarian, have been analyzed in 1997 by Hook and 
Czeizel. In the data from Hungarian they concluded that preconception use of a 
multivitamin containing 800 μg folic acid was associated with a significant 16% 
increase in miscarriage rates compared with women who received trace elements 
(86). In addition, data from the MRC study including all women assigned 
preconception FA treatment, 4000 μg, and reported a nonsignificant 15% increase in 
miscarriage rates (86).The hypothesis these authors mentioned was that folic acid 
may influence the viability of foetuses with malformations. 
A large population-based cohort study with 23,806 births and 2155 miscarriages of 
first pregnancies in China found no evidence that daily intake of 400 μg FA 
influenced their risk for miscarriages (87). Neither did a case–control study on the 
relation between plasma folate levels and the risk of spontaneous abortion. In this 
study, low plasma folate levels were related to a higher risk of miscarriages (76). In 
2000 Windham et al reported that data from a prospective study of women in 
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California, interviewed during their first trimester of pregnancy, supported the 
conclusion of Hook and Czeizel that preconception vitamin increased the occurrence 
of miscarriage. In this study, a nonsignificant 14% increase in the occurrence of 
miscarriage among women who took vitamins during the prenatal period was 
observed and attributed to preconceptional FA use although the supplements taken 
were a mixture of vitamins not FA alone (88). The hypothesis of Windham et al., for 
this phenomenon is that folic acid/multivitamin use prolongs pregnancies that may 
have miscarried very early until they are more likely to be recognized later in 
gestation. The somewhat higher proportion of very early miscarriages between the 
4th and 8th gestational weeks in the trace element group supports this idea. 
1.4.4 Twins 
Swedish researchers have reported that folate supplementation in early pregnancy 
increases the risk of twin births (89;90). And at least three other studies have also 
suggested the possibility of an increase in the occurrence of multiple births (91-93). 
The two Swedish studies described the increased occurrence of dizygotic twins. Only 
6953 women reported the use of FA in early pregnancy among 576,873 women who 
gave birth during that period. After exclusion of women who reported involuntary 
childlessness and women who used ovarian stimulation, and adjusting for year of 
birth, maternal age, parity and smoking, the odds ratio for dizygotic twinning was 
1.71 (90). 
In a large population-based prospective cohort study among young women in China 
with 242,015 births and 1496 multiple births, no increase of multiple births was 
found in women who had taken 400 μg FA supplements compared with those who 
did not (94). Although the available evidence is not conclusive, the large study from 
China which includes many young mothers and where the use of ovarian stimulation 
is not common did not show an increased risk of twinning, after periconceptional FA 
use (94). In this paper, it was suggested that the effect seen in the Swedish study was 
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due to confounding from maternal age and subfertility, in spite of the fact that 
adjustments for these factors had been made. 
Berry et al. suggest that in the Swedish studies is wholly or largely a false result 
based on misclassification of in vitro fertilisation, itself a known risk factor for 
twinning (95;96). In assessing the credibility of the original Swedish reports it is 
useful to consider whether there is a plausible mechanism by which dietary 
supplementation might increase twinning rates. One explanation can be if folate 
and/or multivitamin supplementation reduces the rate of early twin loss it would lead 
to an increase in the number of twin deliveries without any effect on the rate of twin 
pregnancy (97). 
1.4.5 Other health risks 
There are clear benefits in receiving folate to lower homocysteine. There is also 
evidence that excess periconceptional folate can increase the prevalence of the 
C677T-MTHFR TT genotype, which is associated with higher homocysteine levels 
(98). No one knows yet if increasing dietary folate would influence antifolate cancer 
chemotherapy. Folic acid also interferes with antiepileptic drug metabolism in 
epileptic patients and may alter the control of epilepsy by anticonvulsant drugs (98). 
Experimental studies have confirmed that folates are highly convulsant if the 
blood/brain barrier mechanism is circumvented. Fortunately, the risk to patients is 
small because of the barrier mechanism, but the bigger the dose, the longer the 
duration and the greater the damage to the blood/brain barrier, the higher the risk 
(99). 
The strategy of universal fortification of staple foodstuffs with folic acid also presents 
the possibility of life-long exposure to unmetabolized FA. Kelly et al. showed that an 
intake of folic acid in addition to that in the diet of 266 μg/day results in significant 
amounts of unmetabolized folic acid in the blood in adults. This suggests that not all 
FA supplied is available for the remethylation of Hcy to methionine. The 
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homocysteine-lowering response is thus not linear over the whole range, which 
implies an overestimation of the relative bioavailability for dietary folate (18). 
1.5 Strategies 
As mentioned earlier, there are several studies that indicated that increased intake of 
folate for women would reduce their risk of having babies with NTD. In Norway 
only few women reach the recommended 400 μg folate per day. There are several 
options for increasing the folate status of citizens: 
• promotion of intake of foods naturally rich in folate 
• recommendations on the use of folic acid supplements 
• voluntary folic acid fortification of food 
• mandatory folic acid fortification of foods 
 
FIG 2: Several options for increasing the folate status of citizens 
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1.5.1 Promotion of intake of foods naturally rich in folate 
To increase folate intake would require a considerable increase in consumption of 
foods rich in folate such as green leafy vegetables, legumes, and fruits. Even though 
this recommendation is included in most nutrition and health programs, it will take a 
long time to make such a change, and it may be difficult for all citizens to achieve a 
sufficient intake. But according to Brower et al. it is possible that the intake of folate-
dense vegetables and citrus fruits significantly enhances the folate status and 
decreases tHcy concentrations in healthy volunteers. Her test diet compressed 350 g 
of vegetables, one piece of citrus fruit and 200 ml of citrus fruit juice in addition to 
the basal diet, thus achieving a total folate intake on 560 μg /day. This is higher than 
what can be expected to be eaten by the general population (14;100). An intervention 
study in healthy women, Cuskelly et al. found in contrast that dietary advice aiming 
at optimizing folate intake did not increase folate status, whereas supplementation 
with pills or fortified foods did. Folate as natural food folate is relatively ineffective 
at increasing folate status (101). Thus, improving dietary folate intake by health 
campaigns does not appear to be an efficient strategy to increase folate status of 
women of childbearing age sufficiently to prevent NTDs at a population level (101). 
1.5.2 Recommendations on the use of folic acid supplements 
In the EUROCAT report seven European countries, Norway included, had official 
health education initiatives to promote the use of FA supplements. In NNR 1996, an 
intake of 400 μg/day was recommended from the beginning of the pregnancy. In 
1998, the Norwegian Nutritional Council recommended that women should take 
folate supplements prior to and during the first 2-3 months of pregnancy (33). This 
has been followed up with several information campaigns. In spite of this promoting 
the majority of women in all these countries in Europe were not taking folic acid 
supplements periconceptionally. This is reflected in the lack of a clear decline in the 
prevalence of NTD across Europe (32). It has also been shown that the highest use of 
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folic acid supplementation was found in countries that had introduced an official 
health education program to promote use of supplements (32). 
According to several studies the use of FA supplementation by women is positively 
associated with age and socioeconomic status, and inversely with the number of 
pregnancies and with unplanned pregnancies (23;32;102). Almost twice as many 
women with a high educational level used FA in the advised way than those women 
with a lower educational level. 
In a study of Botto et al. recommendations alone did not seem to influence trend in 
NTD up to six year after the confirmation of the effectiveness of folic acid in clinical 
trails (27). Botto and colleagues analyzed 13 birth registries from Europe and Israel 
and found no changes in the trend of incidence of NTDs between 1988 and 1998, 
even though the use of FA supplements had been promoted. 
1.5.3 Fortification 
McNulty et al. have demonstrated that a significant increase in dietary intake of food 
naturally rich in folate is less effective in increasing red cell folate status than is an 
equivalent amount of folic acid via fortified foods. This is thought to be because folic 
acid is more stable than natural folates and hence is more bio available (103). 
Food fortification can provide relatively rapid solutions to address low micronutrient 
intakes at a population level, whilst maintaining traditional dietary patterns (104). 
However, concerns need to be addressed in relation to the hypothetical risk of over-
consumption in individuals outside the at-risk groups or those who choose to eat high 
amounts of fortified foods (104). While there is evidence that food fortification can 
help address nutritional deficiency in some population groups, there is a risk of over 
nutrition in other population groups. 
Fortification is defined by the Codex Alimentarius as the addition of one or more 
essential nutrients to a food, whether or not it is normally contained in the food, for 
the purpose of preventing or correcting a demonstrated deficiency of one or more 
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nutrients in the population or specific population groups (105). The fortification 
vehicle can be either a staple food, or a more-processed commercially-available food, 
and many have been tried. 
Until now the Norwegian government has followed the principle that permissions for 
fortifications are only given for the benefit of health need, to supply the entire 
population or major parts of the population. Traditionally food fortification programs 
in Norway have been designed to: 
•  restore nutrients removed during food processing (iron in whey cheese) 
• add nutrients in substitute foods (the addition of vitamins A and D to 
margarine, a replacement for butter) 
• correct obvious deficiencies in populations (iodine fortification of salt, vitamin 
D in low fat milk) 
Today the applications will be considered with focus on whether the fortification can 
make a health risk or not. 
The recent WHO guidelines on fortification state that the goal of fortification should 
be to provide 97.5% of the individuals in a population with an intake that meets their 
Estimated Average Requirement (EAR) for specific micronutrients without 
exceeding their UL (106). 
There are two ways to do it: Voluntary or Mandatory. 
1.5.4 Voluntary folic acid fortification of food 
Fortification of foods on a voluntary basis is allowed in many countries. In Norway it 
is not permitted to fortify food unless they have received permission from The 
Norwegian Food Safety Authority. In 1995 Australia’s National Food Authority 
permitted the voluntary fortification of flour, bread, savoury biscuits, breakfast 
cereals, pasta, yeast extracts (a popular spread for bread in Australia), fruits and 
vegetable juices, and meal replacements with folate to 100 μg folate per serving 
(107). The voluntary fortification of foods with folic acid in Australia has been 
followed by a significant increase in serum folate and decrease in plasma 
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homocysteine in this community. The difference was greater in subjects who 
consumed at least one folate fortified food per week than subjects who did not use 
folate fortified foods (107). However, only a limited proportion of the permitted 
foods have been fortified under the voluntary folate fortification policy in Australia. 
Breakfast cereals is the most frequently used FA fortified food in Europe, US and 
Australia. Voluntary fortified breakfast cereals contribute 15% of average daily folate 
intakes of British adults (108;109). 
A public health decision in Hungary stimulated flour fortification on a voluntary 
basis, but it remains the only European country to take this action. Unfortunately, 
little is known about the proportion of bread and bread products that are actually 
made with fortified flour or about the effect on folate status or NTD rates in Hungary 
(110). 
Only a few published studies are concerned with intake of fortified foods, and most 
are confined to single food groups or intake of specific nutrients. Godfrey et al. 
recently estimated the impact of fortified foods in France, Germany, Italy, Spain and 
the UK. They concluded that even for high level consumers of fortified foods, these 
consumers were unlikely to obtain more than 10% of their diet in a fortified form 
(111). But according to Rasmussen et al. food survey data for adults from the UK and 
France showed that for frequent consumers of fortified beverages (carbonated 
beverages, juices, fruit drinks and milk), these alone may contribute up to 17% of the 
total diet (112). A large range in the amount of fortified food consumed by children 
and some children can have a very high intake. In the German DONALD study from 
the years 1985–2001 the intake of fortified foods was highest in the youngest age 
groups and the intake of fortified foods in 2 to 3-year-olds contributed with 
9.02±7.80 of the total energy intake. 
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1.5.5 Mandatory folic acid fortification of foods 
Mandatory fortification has been started in about 40 countries throughout the world. 
Most of them are American but some are also African and Asian. Several European 
countries have advocated mandatory flour folic acid fortification over the last 6 years, 
but none has introduced it. In the United States and Canada, folic acid fortification of 
enriched grain products was fully implemented by 1998. Pfeiffer et al recently 
published the largest documentation of folate status since mandatory folic acid 
fortification of enriched cereal-grain products was initiated. These new data provide a 
comprehensive biochemical assessment of folate status in a representative sample of 
the American population in the National Health and Nutrition Examination Survey 
(NHANES) (68). The US population has shifted to significantly higher serum and 
RBC folate concentrations. There is observed increases across all subgroups of age, 
sex, or race-ethnicity. Adolescents and adults have experienced the biggest relative 
increase, children aged 5 year the smallest increase, and elderly persons an 
intermediate increase (68). The Centers for Disease Control and Prevention has 
reported that NTD rates have decreased 26% since fortification, but that additional 
effort is needed to achieve the national goal of a 50% reduction. 
Recent reports indicate that the program is providing approximately twice as much 
folic acid as was originally estimated (79;113;114). This increase is higher than was 
expected from the 70–130 μg/d increase predicted by the US fortification program.  
Since the implementation of folic acid food fortification in Canada, women’s folate 
stores have increased dramatically in also in this country, 50% relative reduction in 
the risk of open NTD has been observed (115). 
Fortification of wheat flour with folic acid has been shown to be effective in 
preventing NTD in Chile. In Chile, the FA fortification of wheat flour with 220 
μg/100 g has been mandatory since January, 2000 (116). The mean intake of wheat 
flour as bread in Chile is very high, approximately 200 g/day. One year after 
fortification there is increases in serum folate and RBC folate of 3.8 and 2.4-fold, 
 36 
respectively, in women of fertile age. Preliminary results show a reduction of 40% in 
the rates on NTD from the pre-fortification period (1999-2000) to post-fortification 
period (2001-June 2002) (116). 
Even in countries with mandatory fortification policies, it is evident that some women 
are at more risk of a low folate status than others. A study in Georgia, USA, showed 
that low folate status was more likely for those not taking FA supplements and those 
less likely to eat breakfast cereal (fortified) regularly. It was also more likely for 
black women, smokers and those using a particular form of contraceptive injection 
(but not contraceptive pills in general) (117). Such women still need special targeting. 
1.5.6 Models 
Several models have been proposed to make the voluntary fortification safe (112;118-
120). The most famous is the model by Flynn et al. They have published an empirical 
model, based on food intakes from several national dietary surveys across Europe, to 
calculate the level of each micronutrient that could be safely added to foods in 
Europe. A number of scenarios have been envisioned at considerably higher 
hypothetical proportions of foods fortified than those in current UK and Irish 
practice. Factors of the model include: micronutrient intakes at the 95th percentile 
level; proportion of fortified foods in the diets of consumers at the 95th percentile of 
food energy intakes; the proportion of foods in the diet to which micronutrients could 
in principle be added; the types of foods that might in practice be fortified. The model 
is based on the tolerable upper intake level (UL) established by the EC Scientific 
Committee on Food (SCF). The model is derived from adult intake data and UL 
established for adults. The results indicate that for all reasonably feasible scenarios all 
micronutrients could be safely added at nutritionally-relevant levels without 
exceeding the UL, with the exception of vitamin A. 
Recently Rasmussen et al have published a model for the Danish Institute for Food 
and Veterinary Research.  The Danish model is based on the model by Flynn et al. It 
employs three main elements, the ULs, the 95th percentile intake of micronutrients 
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from non-fortified foods (CI95) and supplements (SI), and the resulting maximum 
allowance (MA) for fortification. By using these factors, it is possible to estimate the 
level of each micronutrient that can be added to foods without any appreciable risk of 
adverse effects for any age group in the population, including individuals with high 
food intakes. The model is based on the following factors and mathematical 
formulae: 
• UL: the tolerable upper intake level established by the SCF or other expert 
committees. Where no UL has been established, guidance levels (GLs) 
suggested by the UK Expert Group on Vitamins and Minerals (EVM) or 
temporary guidance levels (TGLs) suggested here are used instead; 
• CI95: the current 95th percentile dietary intakes of micronutrients from non-
fortified foods; 
• EI95: the 95th percentile energy intake; 
• SI: supplement intake; daily micronutrient intake from a normal 
vitamin/mineral supplement; 
• MA: maximum allowance for intake of micronutrients from fortified foods: 
MA=UL – (CI95+SI); 
• PFFn: the fraction of foods in the market which is available for fortification;  
• ALA: Acceptable level of addition with each nutrient per 100 kcal portion of 
the food (112). 
ALA = MA / EI95 * PFFn 
The main difference between the two models is that the Danish model takes into 
account the regular use of a vitamin and mineral supplement and differentiates ULs 
for children of all ages. They also estimate that 50% of fortifiable foods will be 
fortified and, hence, that the MA can be distributed among only 25% of the energy 
intake. 
Norwegian Scientific Committee for Food Safety have evaluated the Danish model 
for addition of vitamins and minerals to food, the conclusion is that it can bee a good 
instrument to assess fortification of food in Norway (121). The Authority wanted the 
prerequisite in the model that 25% of the energy is to be derived from fortified foods, 
to be reduced to 10 E%. When they used Norwegian data in the model they found 
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that the safe addition of FA to foods can be 20 μg/100 kcal without health risk to any 
consumer group. 
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2. Objectives 
The aim of this study was to determine a level of mandatory fortification that 
maximised folic acid intake for the target group, women of child-bearing age, to 
assist in achieving their recommended intake of 400 μg of FA per day, whilst 
preventing a significant proportion of people in the target and non-target groups 
exceeding upper safe levels of intake. In considering mandatory fortification of food 
with folic acid, flour and bread were selected as the food vehicles. 
The effect of various fortification and supplementation scenarios will be studied for 
children 4, 9 and 13 years old, adult men, women of child-bearing age and pregnant 
women. 
The following dietary intake assessments were considered: 
• Folate intake from food alone 
• Folic acid intake from different mandatory fortification scenarios 
• Folic acid intake from voluntary fortification of some foods 
• Folic acid intake from voluntary fortification of some foods and supplement 
use 
• Folic acid from mandatory and voluntary fortification and supplements 
• Folates from food, , mandatory, voluntary fortification and supplements 
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3. Methods 
3.1 Foods 
Two potential food vehicles for folic acid mandatory fortification and six for 
voluntary fortification were selected. 
3.1.1 Mandatory folic acid fortification 
Wheat flour and bread were selected as potential food vehicles for folic acid 
fortification, since at least 50 g of these foods were consumed, by more than 90% of 
women of child-bearing age. Three fortification levels were used to examine the 
effect of mandatory fortifying of the selected food vehicles on folic acid intakes: 
-Flour: 140, 190 and 240 μg/100 g flour 
-Bread: 100 and 200 μg/100 g bread 
The flour fortification levels was based on the concentration the US food and Drug 
Administration introduced in US (140 μg), in UK Committee on Medical Aspects of 
Food and Nutrition Policy (COMA) has proposed a concentration of 240 μg/100 g as 
a optimal level (122), and in Ireland 190 μg/100g is the level that Ireland is being 
considered. 
The bread fortification levels were also based on different countries experiences.  
Fortified bread began in Hungary in 1998, the daily intake of folic acid is estimated 
to about 100 μg in 100 g of bread (110). 
Hertrampf et al. has assessed the effectiveness of the FA flour fortification program 
on bread in Chile. The mean folate concentration of the mean FA content of bread is 
2020 μg/kg (116). 
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3.1.2 Voluntary folic acid fortification 
Sweet and unsweetened breakfast cereals, juice, nectar, yoghurt and milk were 
selected as possible products for voluntary fortification. In the calculation of 
voluntary fortification 20 μg/100 kcal were used. This is based on the Norwegian 
Scientific Committee for Food Safety results then they evaluated “The Danish model 
for addition of vitamins and minerals to food”. 
Because the fortification level is per 100 kcal, breakfast cereals had to be calculated 
both as sweetened and unsweetened. For the same reason I had to calculate milk in 
four different ways. See appendix 1. 
Table 3: Voluntary fortified 20 μg/100 kcal 
Food μg FA/100g 
Breakfast cereals unsweetened 69 
Breakfast cereal sweetened 77 
Juice 9 
Nectar 8 
Yoghurt (3% fat) 16 
Milk, whole milk 13 
Milk, low fat 1,5% 9 
Milk, low fat 0,7% 8 
Milk, skimmed 7 
 
3.1.3 Supplement 
Folic acid intakes from dietary supplements (200 μg) were added to the individual 
folic acid intakes for three fortification scenario to yield total folic acid intakes. 
3.2 Food intake data 
The food data is from three large Norwegian dietary surveys, among children aged 4, 
9 and 13 years, men aged 16-79, females aged 16-49 years and pregnant women. 
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3.2.1 Ungkost II 
In 2000, a nationwide dietary survey using 4-days records with pre-coded food diary 
was conducted in representative samples of schoolchildren in the 4th and 8th grades. 
The pre-coded diary has been validated (123). In 2001 a nation-wide study was 
conducted among 4-year-old children using a similar design as among these 9- and 
13-year-old students. The surveys were collaboration between the Norwegian 
Directorate for Health and Social Welfare, Department of Nutrition, Norwegian Food 
Control Authorities and the Institute for Nutrition Research, University of Oslo. The 
4-day period consisted of three weekdays and one weekend day. Participants in the 
8th grade recorded their diet themselves, while parents filled in the diary together 
with the 4-years old and students in the 4th grade. Along with the diary each 
participant received a photographic booklet which embodied 13 colour photograph 
series, each with four different portion sizes ranging from small to large. As 83% of 
the selected subjects participated, the data may be considered as representative for 
this age group in Norway. 
3.2.2 Norkost II 
The Norkost study was a nation-wide survey of a representative random sample of 
the adult Norwegian population and was undertaken by the National Nutrition 
Council in collaboration with the National Food Authority, Institute for Nutrition 
Research and the Norwegian Statistical Office. Approximately five thousand subjects 
were recruited and 2672 questionnaires were found adequately completed 
(participation rate 53%). A self-administered, quantitative food-frequency 
questionnaire (FFQ) was used for the data collection. It was designed to cover the 
whole diet including approximately 180 food items, grouped according to the 
Norwegian meal pattern. The selection of foods, portion sizes and frequencies was 
based on experience gained from earlier dietary surveys and the food frequency 
questionnaire has been validated (21;124) 
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3.2.3 The Norwegian Mother and Child Cohort Study 
This study is a subproject in the Norwegian Mother and Child Cohort Study (MoBa) 
(125). In brief, MoBa is a pregnancy cohort that in the period 1999 to 2006 has 
included more than 75 000 pregnancies, and that aims to include 100 000 by the end 
of 2007. See appendix 2. 
The sample used here includes 19.711 pregnancies using version 1 of the quality-
assured data files made available for research in 2005. Here the pregnant women 
answered version 2 of the food frequency questionnaire, which has been validated 
(126). The data was collected from February 2002 until April 2003, and the women 
filled in how often they have been eating different food items since they became 
pregnant. The women answer the questionnaire in week 17-18 of the pregnancy. 
Reported intakes of foods and supplements are converted into daily intakes by 
FoodCalc (127) and the Norwegian food composition table (8). 
3.2.4 Handling of data 
From the “Ungkost” and “Norkost” surveys, data was computed for each person by 
using a food database and software system for calculation of food, energy and folate 
intake, developed at the Institute for Nutrition Research, University of Oslo, called 
KBS. The food database was based on the official food composition table, from 1995, 
(8). KBS is continuously supplemented with data on new food items. 
KBS were used to find intake of bread, sweet and unsweet breakfast cereals, juice, 
nectar, yoghurt and milk with different fat content, for each person. In KBS it is also 
possible to find the intake of raw material, there I could find total intake of wheat 
flour from bread, cakes and flour containing dishes, for each person. I have received 
the corresponding data from the MoBa, except folate from each food product. 
Data analyses were performed with the statistical software Statistical Package for 
Social Sciences (SPSS) 12.0 for Windows. The result from KBS and the MoBa, was 
saved as an Excel-file and imported to SPSS for further analyse. 
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The intake of wheat flour, bread and the selected foods for voluntary fortification 
(breakfast cereals, juice, nectar, yoghurt and milk) are presented in table 4 as mean 
intake and percentiles 5 and 95 per person per day. 
Table 4 Intake of wheat flour, bread, breakfast cereals, juice, nectar, yoghurt, and milk g/day mean (p5 - 
p.95) 
Product Children  
4 y 
n = 391 
Children 
9 y 
n = 810 
Children 
13 y 
n = 1005 
Men 
16-79 y 
n = 1291 
Women 
16-49 y 
n = 928 
Women 
pregnant 
n = 19711 
Wheat flour 
mean, g/d 
p5-p95, g/d 
 
66 
27-113 
 
92 
36-165 
 
96 
30-193 
 
141 
62-248 
 
98 
43-167 
 
117 
36-229 
Bread 
mean, g/d 
p5-p95 
 
94 
41-174 
 
115 
43-217 
 
121 
35-239 
 
212 
90-390 
 
143 
60-245 
 
222 
61-406 
Breakfast cereals 
mean, g/d 
p5-p95, g/d 
 
13 
0-50 
 
17 
0-86 
 
13 
0-65 
 
14 
0-67 
 
10 
0-46 
 
11 
0-55 
Juice 
mean, g/d 
p5-p95, g/d 
 
26 
0-131 
 
48 
0-150 
 
58 
0-267 
 
62 
0-288 
 
68 
0-300 
 
108 
0-300 
Nectar 
mean, g/d 
p5-p59, g/d 
 
18 
0-122 
 
21 
0-266 
 
18 
0-133 
 
14 
0-54 
 
18 
0-108 
 
72 
0-400 
Yoghurt 
mean, g/d 
p5-p95, g/d 
 
58 
0-163 
 
42 
0-165 
 
37 
0-175 
 
21 
0-112 
 
32 
0-126 
 
66 
0-210 
Milk 
mean, g/d 
p5-p95, g/d 
 
293 
57-573 
 
345 
35-735 
 
274 
0-725 
 
466 
10-1154 
 
316 
4-801 
 
488 
39-1278 
y = years of age 
p5-p95 = percentiles 5 to 95 
 
The observations in the surveys have a distribution that is similar to a normal 
distribution, so the results are presented as mean. Some of the results are also given at 
percentile 5 and percentile 95. 
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4. Results 
4.1 Folate intake from food 
Women aged 16-49 was the group who had highest concentration of folate in their 
diet, the mean intake of dietary folate was 309 μg /10 MJ. The pregnant women had a 
mean intake at 275 μg /10 MJ which is similar to the men’s mean at 288 μg/10 MJ 
(table 5). 
As shown in table 5, the average pregnant woman had a higher folate intake (272 
μg/day) compared with the average among fertile women (250 μg). Despite this it is 
still only 50% of the RI at 500 μg/day. Only 3% of the fertile women had an intake 
according to RI (400 μg). For men the average intake of diet folate was 309 μg, even 
if that is similar to the recommendations, 54% get an intake below RI (table 5). 
Almost all children aged 4 and 9 years, but only half of those aged 13 reached the RI. 
The average intake of diet folate was 153 μg for children aged 4 years, 196 μg for 
those aged 9 years and 220 μg for those aged 13. 
Table 5: Intake of dietary folate (μg/day), energy (MJ/day) and dietary folate per 10MJ and the 
percentage of folate according to NNR recommendations. 
 Children 
4 y 
n = 391 
Children 
9 y 
n = 810 
Children 
13 y 
n = 1005 
Men 
16-79 y 
n = 1291 
Women 
16-49 y 
n = 928 
Women 
pregnant 
n = 19711 
Intake of diatery folate 
mean, μg/d 
p5-p95, μg/d 
 
153 
89-239 
 
196 
107-295 
 
220 
99-408 
 
309 
172-511 
 
250 
133-397 
 
272 
143-452 
Intake of energy 
mean, MJ/d 
p5-p95, MJ/d 
 
6,2 
4,3-8,4 
 
8,2 
5,3-12 
 
8,8 
4,6-14,1 
 
11,0 
6,0-18,4 
 
8,3 
4,7-13,1 
 
9,9 
6,1-15,1 
Diatery folate concentration 
mean, μg/10 MJ 
p5-p95, μg/10 MJ 
 
245 
170-334 
 
241 
167-335 
 
252 
152-418 
 
280 
210-391 
 
302 
208-426 
 
275 
182-394 
Intake of dietary folate 
% ≥ RI 
 
98 
 
89 
 
45 
 
46 
 
5 
 
3 
y = years of age 
p5-p95 = percentiles 5 to 95 
RI = Recommended Intake (see table 1 for recommended levels) 
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In table 5 the percentage of how many would meet or exceed the NNR 
recommendations are presented. When considering the possible adverse effects of 
high intakes of folate, it should be borne in mind that the NNR just has UL for intake 
of folic acid. No UL is set for food folate. Here is also the percentage given for the 
intake below NNR recommendations, there is not the same as lower level. 
4.2 Different mandatory fortification scenarios 
If mandatory fortification of flour with folic acid was introduced in Norway at the 
level decided by FDA in USA in 1998 (140 µg FA/100 g flour), the average adult 
woman below 50 years would receive 387 μg folate per day, i.e. they would not quite 
reach the recommended intake level of 400 µg folate per day (table 6). As shown in 
table 7, 41% would meet or exceed the recommended level, compared to 71 % if the 
higher level now proposed in England (240 µg) was implemented. 
As shown in table 6, the average pregnant women would receive 436 μg per day if 
Norway should introduce mandatory fortification at 140 μg/100g flour, compared to 
553 μg if the mandatory level would be 240 μg/100 g flour. Because the 
recommended level is 500 μg per day for the pregnant women, only 29% or 55% 
would reach the RI (table 7).  
 47
 
Table 6: Intake of FA in different mandatory fortification scenarios with and without dietary folat, μg 
per day, mean (p5 - p.95) 
Fortification level Children 
4 y 
Children 
9 y 
Children 
13 y 
Men 
16-79 y 
Women 
16-49 y 
Women 
pregnant 
140 μg FA/100 g flour 
FA only 
mean, μg/d 
p5-p95, μg/d 
DF + FA 
mean, μg/d 
p5-p95, μg/d 
 
 
92 
38-159 
 
245 
140-380 
 
 
129 
50-231 
 
324 
177-505 
 
 
150 
44-336 
 
354 
154-669 
 
 
198 
86-347 
 
507 
277-812 
 
 
137 
61-234 
 
387 
214-593 
 
 
164 
51-321 
 
436 
221-727 
190 μg FA/100 g flour 
FA only 
mean, μg/d 
p5-p95, μg/d 
DF + FA 
mean, μg/d 
p5-p95, μg/d 
 
 
125 
52-215 
 
278 
158-433 
 
 
175 
67-313 
 
370 
199-590 
 
 
198 
59-410 
 
402 
170-765 
 
 
269 
117-471 
 
577 
550-311 
 
 
186 
83-318 
 
436 
240-672 
 
 
223 
69-436 
 
495 
246-836 
240 μg FA/100 g flour 
FA only 
mean, μg/d 
p5-p95, μg/d 
DF + FA 
mean, μg/d 
p5-p95, μg/d 
 
 
158 
66-272 
 
311 
174-489 
 
 
221 
85-395 
 
416 
220-675 
 
 
246 
75-493 
 
450 
190-855 
 
 
339 
148-595 
 
648 
344-1077 
 
 
235 
104-401 
 
483 
261-746 
 
 
282 
87-550 
 
553 
267-946 
100 μg FA/100 g bread 
FA only 
mean, μg/d 
p5-p95, μg/d 
DF + FA 
mean, μg/d 
p5-p95, μg/d 
 
 
94 
41-174 
 
246 
144-396 
 
 
115 
43-217 
 
311 
175-483 
 
 
121 
35-239 
 
326 
152-573 
 
 
212 
90-390 
 
521 
284-841 
 
 
143 
60-245 
 
394 
211-608 
 
 
222 
61-406 
 
494 
248-810 
200 μg FA/100 g bread 
FA only 
mean, μg/d 
p5-p95, μg/d 
DF + FA 
mean, μg/d 
p5-p95, μg/d 
 
 
187 
82-348 
 
340 
191-555 
 
 
230 
86-435 
 
426 
29-691 
 
 
242 
71-471 
 
446 
196-803 
 
 
424 
180-780 
 
733 
690-387 
 
 
286 
120-490 
 
537 
273-847 
 
 
444 
122-812 
 
716 
322-1201 
y = years of age 
p5-p95 = percentiles 5 to 95 
FA = Folic Acid 
DF = Dietary Folate 
 
At the highest mandatory fortification of bread (200 μg/100 g) 78% of the women of 
childbearing age would reach RI. The equivalent for pregnant women was 81%. In 
the same scenario the children aged 4 and 9 years had the highest intake, approximate 
50-60% of them would get an intake of total folate over UL. At the lowest level of 
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fortification of flour (140 μg/100 g), 18%, 19% and 7% of children aged 4, 9 and 13 
respective, would get an intake over UL (table 7). 
The scenario where least persons get an intake over UL is when bread is fortified 
with 100 μg/100 g. This study show that only 19% of the children aged 4 years and 
15% aged 9 years reaches UL. However, in this case 56% of the fertile women and 
57% of pregnant women did not reach the recommended intake (table 7). 
Table 7: Percentage of the Norwegian population, by age group, receiving folate intakes, below, 
according to and above the NNR recommendations, food folate and FA under simulated fortification 
scenarios of flour and bread. 
DietaryFolate Children 
4 y 
Children 
9 y 
Children 
13 y 
Men 
16-79 y 
Women 
16-49 y 
Women 
pregnant 
+140 μg FA/100g flour 
% < RI 
% RI 
% > UL 
 
0 
82 
18 
 
1 
80 
19 
 
12 
81 
7 
 
8 
90 
2 
 
57 
41 
0 
 
71 
29 
0 
+190 μg FA/100 g flour 
% <RI 
% RI 
% > UL 
 
0 
66 
34 
 
1 
65 
35 
 
8 
80 
12 
 
4 
92 
4 
 
42 
57 
1 
 
58 
41 
2 
+240 μg FA/100 g flour 
% <RI 
% RI 
% >UL 
 
0 
50 
50 
 
0 
49 
51 
 
6 
75 
19 
 
2 
91 
7 
 
30 
70 
0 
 
45 
51 
4 
+100 μg FA/100g bread 
% <RI 
% RI 
% >UL 
 
0 
81 
19 
 
1 
84 
15 
 
15 
82 
4 
 
7 
91 
2 
 
56 
44 
0 
 
57 
42 
1 
+200 μg FA/100 g bread 
% <RI 
% RI 
% >UL 
 
0 
41 
59 
 
1 
46 
53 
 
6 
77 
17 
 
1 
85 
15 
 
22 
76 
2 
 
19 
68 
13 
y = years of age 
RI = Recommended Intake 
UL = Upper Level 
4.3 Voluntary fortification of some food 
Estimated folic acid intakes of the groups consuming specific amounts of FA from 
voluntary fortified foods are presented in table 8. Milk is the product that contributes 
with most FA. If the groups choose voluntary fortified milk, it contributes with 
almost: 38, 26, 24, 21, 7 and 10% of the recommended daily intake for the groups 
respective. 
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For the pregnant women the average intake of folate would increases from 272 μg to 
349 μg, if they choose all products. This means that 25% more of the pregnant 
women reaches the recommended intake. The corresponding number for fertile 
women is 10%.  
Table 8: Folic acid intakes from voluntary fortification μg/day mean (p.5 p.95) 
Product Children 
4 y 
Children 
9 y 
Children 
13 y 
Men 
16-79 y 
Women 
16-49 y 
Women 
pregnant 
Breakfast cereals 
mean, μg/d 
p5-p95, μg/d 
 
9 
0-38 
 
12 
0-64 
 
9 
0-48 
 
10 
0-47 
 
7 
0-33 
 
8 
0-40 
Juice 
mean, μg/d 
p5-p95,μg/d 
 
2 
0-12 
 
4 
0-20 
 
5 
0-24 
 
6 
0-26 
 
6 
0-27 
 
10 
0-27 
Nectar 
mean, μg/d 
p5-p95, μg/d 
 
1 
0-10 
 
2 
0-12 
 
1 
0-11 
 
1 
0-4 
 
1 
0-4 
 
6 
0-32 
Yoghurt 
mean, μg/d 
p5-p95, μg/d 
 
9 
0-26 
 
7 
0-26 
 
6 
0-28 
 
3 
0-18 
 
5 
0-20 
 
11 
0-34 
Milk 
mean, μg/d 
p5-p95, μg/d 
 
30 
6-59 
 
34 
3-72 
 
26 
0-70 
 
43 
0-42 
 
27 
0-37 
 
43 
4-111 
All five products 
mean, μg/d 
p5-p95, μg/d 
 
52 
16-104 
 
59 
14-131 
 
48 
5-116 
 
63 
8-150 
 
47 
7-112 
 
77 
16-169 
y = years of age 
p5-p95 = percentiles 5 to 95 
 
The 4 years old children are the group who get most FA from the voluntary fortified 
food per 10 MJ, presented in table 9. If they used all the products the voluntary 
fortification will provide 65% of the daily recommendation. 
Table 9: Folic Acid intake from voluntary fortified: Breakfast cereals, Juice, Nectar, Yoghurt and Milk 
μg/ 10 MJ, mean (p.5 p.95) 
Voluntary 
fortification 
Children 
4 y 
Children 
9 y 
Children 
13 y 
Men 
16-79 y 
Women 
16-49y 
Women 
pregnant 
FA concentration 
mean, μg/10 MJ 
p5-p95, μg/10 MJ 
 
83 
27-159 
 
30 
0-96 
 
55 
7-123 
 
57 
9-122 
 
56 
10-118 
 
76 
20-148 
y = years of age 
p5-p95 = percentiles 5 to 95 
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4.4 Voluntary fortification and supplements 
Of the fertile women and pregnant women 83% would get an intake over RI, if taking 
FA supplement with 200 μg per day in addition to voluntary fortification and dietary 
folate.  
The percentage of participants with risk of an intake above the UL for the groups 
consuming specified amounts of FA from voluntary fortified foods and dietary 
supplements (200 μg) in addition to dietary food folate, are presented in Table 10. 
None of the groups reached UL from just the fortification and supplements, but taken 
into account the contribution from dietary food folate. Almost all the children aged 4, 
and 75% aged 9 years, are risking to reach a daily intake of folate above UL if taking 
FA supplement with 200 μg per day in addition to voluntary fortification and dietary 
folate. 
Table 10: Folate intakes from voluntary fortification selected foods and if they are taking a FA 
supplement with 200μg in addition to dietary food folate μg/day mean (p.5 p.95) 
 Children 
4yy 
n = 391 
Children 
9 y 
n = 810 
Children 
13 y 
n = 1005 
Men 
16-79 y 
n = 1291 
Women 
16-49 y 
n = 928 
Women 
pregnant 
n = 19711 
Intake of folate 
mean, μg/d 
p5-p95, μg/d 
% >UL 
 
405 
314-525 
99 
 
454 
338-614 
75 
 
453 
319-654 
9 
 
572 
400-827 
2 
 
496 
352-694 
0 
 
549 
375-791 
1 
y = years of age 
p5-p95 = percentiles 5 to 95 
UL = Upper Level intake (see table 2 for recommended levels) 
4.4.1 Total Folic Acid from all sources 
The results from  my model calculations including the assumption that flour or bread 
are fortified with FA to varying degrees, in addition to the voluntary fortification and 
use of a supplement of 200 μg, is presented in table 11. At the lowest level of 
mandatory fortification of wheat flour (140 μg/100 g), it was estimated that only 2% 
of the women of child-bearing age would get an folate intakes below 400 μg/day, and 
with the lowest mandatory fortification of bread (100 μg/100 g) 3% of the women 
would get an intake below 400 μg/day. 
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Children aged 4 years old were the only group to get an intake of total FA over UL in 
all scenarios. All children aged 9 years reached UL in the two highest levels of the 
flour fortification scenarios and the highest level of fortification of bread. None of the 
other groups reached an intake over the UL. 
Table 11: Intake of Folic Acid μg/day from voluntary fortification and 200 μg FA-supplements and FA 
from different mandatory fortification scenarios, mean (p5 - p.95) 
FA from voluntary 
fortification and 200μg 
FA supplements 
Children 
4 y 
n = 391 
Children 
9 y 
n = 810 
Children 
13 y 
n = 1005 
Men 
16-79 y 
n = 1291 
Women 
16-49 y 
n = 928 
Women 
pregnant 
n = 19711 
+140 μg FA/100 g flour 
mean, μg/d 
p5-p95, μg/d 
 
344 
273-426 
 
387 
287-503 
 
383 
270-537 
 
461 
324-656 
 
384 
289-508 
 
441 
298-633 
+190 μg FA/100 g flour 
mean, μg/d 
p5-p95, μg/d 
 
377 
291-477 
 
433 
308-588 
 
431 
285-628 
 
532 
356-781 
 
433 
313-592 
 
500 
320-742 
+240 μg FA/100 g flour 
mean, μg/d 
p5-p95, μg/d 
 
410 
305-528 
 
479 
330-673 
 
479 
302-726 
 
603 
387-902 
 
482 
334-679 
 
559 
340-853 
+100 μg FA/100 g bread 
mean, μg/d 
P5-P95, μg/d 
 
345 
282-431 
 
374 
277-497 
 
369 
261-515 
 
784 
516-1152 
 
390 
285-526 
 
499 
319-718 
+200 μg FA/100 g bread 
mean, μg/d 
p5-p95, μg/d 
 
439 
328-599 
 
489 
328-702 
 
490 
298-743 
 
996 
617-1520 
 
534 
346-763 
 
721 
387-1115 
y = years of age 
p5-p95 = percentiles 5 to 95 
 52 
5. Discussion 
My results suggest that it is impossible to fortify food with FA in Norway at a level 
that ensures that the majority of women in the target group will consume 400 μg 
folate/day, without more than 5% in other population groups being exposed to folic 
acid in amounts exceeding the UL. This is accordance with a similar report from New 
Zealand (128). 
Folate has received much attention as a vitamin that can protect against many 
diseases. According to the results from Norkost 88% of men reach the intake 
recommended in NNR, whereas the results from MoBa indicate that only 3% of the 
pregnant women reach the recommended intake from non fortified foods. Several 
strategies to increase the folate status in the population have been discussed in 
Norway (129), one of them is mandatory fortification. If mandatory fortification of 
flour with folic acid was introduced in Norway at the same level as it is in USA (140 
µg FA/100 g flour), 41% of the fertile women and 29% of the pregnant women 
would reach the RI. In the same scenario almost 20% of the children aged 4 and 9 
years would exceed UL. This is in accordance with a recent Swedish report (130). At 
the highest level of mandatory fortified wheat flour (240 μg/100 g) it was estimated 
that 30% of fertile women and 45% of the pregnant women still would receive folate 
intakes below RI. The highest folate intake with this fortification strategy would be 
among children aged 4 and 9 years, more than 50% of them would have an intake of 
total folate over 300 μg and 400 μg respectively. 
Mandatory fortification is non-specific and it affects both the target group and all 
non-target groups. For this reason, fortification must be safe for all groups. In this 
study the most vulnerable group is the children aged 4 years. This is in agreement 
with other studies (68;114). In my study more than half of them would get more than 
UL of total folate, if the flour had been enriched with 240 μg FA. None of them 
would reach UL of FA only. When adding voluntary fortification and supplement 
almost all of them get more than 300 μg FA. 
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The hypothetical intake in this study does only represent the part of the population 
that use the voluntary fortified products. In the scenarios with supplement, 200 μg 
have been added to all groups even for children aged 4 years, this might be a to high 
estimation. According to Ungkost only 42% of the 4 years old children who used 
supplements containing FA, had an intake of 200 μg FA from supplements. On the 
Norwegian market to day there are a lot of different supplements designed for 
children, most of them contain 75-200 μg FA. 
If Norway as the US should fortify flour with 140 μg/100 g in addition to voluntary 
fortification and a supplement with 200 μg FA, the average intake of FA would be 
344, 387, 383, 461, 384, 441μg, for 4, 9, 13 years old children, men, fertile women 
and pregnant women respective. This will come in addition to the dietary folate. This 
scenario will not be realistic in Norway, as long we have the law we have today, 
because if Norway go for mandatory fortification, voluntary fortification with FA 
will not be permitted. 
The folic acid intakes estimated in this study may be overestimated. In the hypothetic 
mandatory fortification scenarios all wheat flour and all bread have been fortified. 
The last year the import of “bake of” and dough has increased in Norway, 
approximate 10% of bread is imported today (131). On the other hand, we do not 
know whether these products might be fortified in the future. 
5.1 Choice of potential food vehicle for mandatory 
fortification 
Wheat flour fortification is a good choice, because there are very few flour mills 
supplying the Norwegian market. Thus, the task of implementing and monitoring FA 
fortification of flour would be simpler than for foods with numerous manufacturers 
and suppliers. 
Breads fortified at 200 μg/100 g provided folate to the greatest number of the target 
groups, 80% of them reached RI. In Norway there are five main bread producers. The 
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largest of them provide approximate 30% of the bread in Norway therefore, as for 
wheat flour, the task of implementing and monitoring fortification should be 
relatively simple. Fortification of bread would result in significantly fewer foods 
being fortified than if flour were to be fortified, thus providing more choice for 
consumers. 
Celiac patients should also be considered since they have a higher total plasma 
homocysteine level than the general population, indicative of a poor vitamin status 
(132). Their diet would not be reached, if we just choose wheat flour or traditional 
bread, and they might be vulnerable to inadequate intake of folate. If it will be 
mandatory fortification in Norway their diet should be considered separately and 
gluten free flour would have to be fortified in the same amount as regular flour. 
Liquid milk can be a potential food vehicle for mandatory fortification. Studies have 
suggested that folic acid fortified milk is an efficacious method increasing folate 
status (133). In this study I did not include milk as a potential product for mandatory 
fortification because children are frequent consumers of milk, and so may be exposed 
to excessive amounts of folic acid. This is a decision I regret, especially because it 
seems to be a good source for pregnant women. In addition, as for wheat flour, the 
task of implementation and monitoring of fortification should be relatively simple 
because there are only two main dairies in the Norwegian market. 
5.2 Recommendations 
In the last decade the folate recommendations from NNR has increased. For women 
in fertile age the recommendation before 1996 was 200 μg, in NNR -96 it increased 
to 300 μg, the last recommendation in NNR -04 is 400 μg total folate. The value for 
RI includes a margin accounting for variations in requirement and physiological 
factors influencing the requirement. It is important to distinguish between the average 
requirement (AR) for folate and the recommended intake. The recommended intake 
represents more than the requirement for the average person and also covers the 
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individual variations in the requirement for the vast majority of the population group. 
In this study I have only used RI because it is important that as many of the target 
group as possible get enough folate to reduce the risk for NTDs. If using AR instead 
of RI 76% of the fertile women would reach the recommendation from non-fortified 
food and that indicate there are not so many individuals who need an increased folate 
intake. In addition to that, all women in childbearing age are not capable of becoming 
pregnant, and not all women capable of becoming pregnant will be so. In that point of 
view the amount of women who need 400 μg folate decreases.  
In Norkost the FFQ is the method used in assessing food intake. The ability for this 
method to quantify the absolute intake of foods and nutrients is in general limited. 
Even if we had known the absolute intake, it must be emphasised that the intake 
value can never decide whether the intake is adequate or not, it can only indicate the 
probability that it is adequate. Knowledge of folate status in Norway is limited. 
Although a few studies have measured folate in blood, this has not been related to 
disease, and there is little knowledge of the distribution of potential folate deficiency 
in subgroups of the population (134). The calculated folate intake in this study is not 
absolutely true values because the food composition tables which have been used 
have an error margin. There is today no analytic method with a status as reference 
method for the measurement of natural folate in foods since all methods are 
complicated by difficulties in sample preparation, including extraction, deconjugation 
and purification (131).  
The term UL can be very confusing. The “tolerable-upper-limit concept” was used by 
the US Food and Drug Administration (FDA) to limit the folic acid concentrations 
required in fortification. NNR-96 also based its recommendation on total folate 
consumption, with an upper limit of 1000 μg a day. Later it has been noted that it was 
incorrect to set a tolerable upper limit of total folate, rather it should be set in terms of 
synthetic folic acid only, and so it is in NNR -04. There is no evidence for risk 
associated with high intake of folate from natural sources and there are different 
views about the risk related to more than 1000 μg FA (13). The UL for children and 
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adolescents is adjusted on the basis of mean bodyweight. This is very uncertain level, 
it is possible that it can be much higher but it can be also much lower –we don’t 
know before more studies have been done. Several intervention studies with FA 
supplementation are in progress to establish its effect on mortality and morbidity 
(47), unfortunately none of them are designed to discover any side effects of a 
decreased use of FA. 
The FA will always be in addition to folate from food. So far, we don’t know if high 
intake of folic acid in addition to dietary folate can be a risk for children. More 
studies are needed. It may be that a complex intake of DF and FA needs to be studied 
over long time, before conclusions are made regarding UL. Because of this I have 
estimated both the total folate intake and the intake of FA. This is in agreement with 
the advice from The Swedish Council on Technology Assessment in Health Care 
(SBU) to The Swedish National Administration (SLV) (130). 
The mix of dietary folate and folic acid can be confusing because the bioavailability 
of folate is 50-98% relative to FA depending on the folate source (13-15). Although 
the differentiation between folate forms is important, I have not accounted for the 
differences in bioavailability of natural folate and FA in this study, because in the 
NNR the bioavailability of the food folate have been taken into consideration. If 
NNR as US had used DFE, a higher amount of people in my hypothetical models of 
fortification, would have reached an intake according to RI. 
5.3 Vitamin B12 
There have been no reports of epidemics of neurological complications due to 
vitamin B12 deficiency, in countries that have mandatory fortification (68;77). With 
the possible consequences of masked vitamin B12 deficiency from folate fortification 
(29), perhaps it would be better to fortify with both folic acid and vitamin B12. 
Concentrations of B vitamins are frequently inadequate in late life, folate as well, and 
many of the elderly will get benefits from fortification. Fortification with vitamin 
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B12 would not only help elderly, it will also benefit vegetarians and alcoholics who 
are known to have risk for low vitamin B12 status. 
There are also other risks than “masking” B12 deficiency. Recently a report from 
India show that children born of mothers with low B12 but high folate status were the 
most adipose and the most insulin resistant (135). The imbalance between folate and 
vitamin B12 are also associated with other adverse effects as a relation between high 
serum folate and cognitive impairment is reversed in subjects who have a low vitamin 
B12 status(136). The problem is that we do not know if it can be any unexpected 
outcomes. There can be a risk that high folate and high vitamin B12 status together 
can influence other metabolic effects. 
5.4 Strategies 
Supplementation with folic acid and stimulation of the consumption of foods 
naturally rich in folate are both useful strategies to increase folate status (33). 
However, these two strategies are not effective at a population level for the 
prevention of NTD. In Norway it is suggested that approximately half of the 
pregnancies are unplanned (33). Then the recommendation that supplementation 
should start before conception is simply not realistic. 
As soon as the outcomes of the clinical trials of NTD became known and accepted, 
public health authorities in most countries, Norway included, advised women of 
childbearing age to increase their daily intake of folate to 400 μg. Although the 
advice was sensible and prudent, now more than a decade later, it is clear that putting 
an effective prevention strategy based on public awareness into place has been much 
more difficult than originally anticipated. Unfortunately, FA-promotion efforts 
targeting childbearing women haven’t been as successful as expected in decreasing 
the level of NTD. However, there has been an increased knowledge of folate in the 
target group (137). And the use of diet supplements has expanded over the last 
decade (137). Despite the measures taken to date, the majority of women in all 
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countries surveyed are not taking FA supplements periconceptionally. The big 
challenge is the timing. Mandatory fortification affects the whole population and 
covers also unplanned pregnancies, and this appears to be the most effective public 
health strategy to prevent NTD, even though stimulation of folate rich food and 
promoting the use of FA supplement should be used at the same time. 
Only five products were used in the modelling of voluntary fortification in this study. 
According to the results the FA intake was increased with 52, 59, 48, 63, 47 and 77 
μg respective for 4, 9, and 13 years old, men, fertile women and pregnant women. 
The minimum amount of FA required to prevent NTD will never be known with 
certainty because further randomised trials are unethical. Therefore, any strategy that 
increases red blood cell folate in women of childbearing age should reduce the 
number of NTD-affected births. There are several reasons to believe that it will be a 
higher intake of folic acid from voluntary fortification in the future. First it is possible 
that more products will be enriched. According to German estimates it can be realistic 
to account that up to 20% of the total diet can be voluntary enriched in the future 
(138).  
Another reason is that manufacturers may also add more folic acid than claimed on 
the food label. The use of overages when adding nutrients to food products is 
common practice in the food industry. According to reports from US, the folate 
content of a food may be considerably higher, in some cases over 200% higher, than 
that indicated on the food label (79;139). 
A third reason is that the industry has the necessary resources to inform the 
population through campaigns. Commercial companies have a larger ability to give a 
message to the people than a governmental founded campaign. If the commercial 
companies see a possibility to make money on folic acid’s health benefits, they are 
probably willing to invest a rather large amount of money to be able to release the 
first product on the market. 
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If you on top of this add that FA supplements uses are increasing, the room for 
mandatory fortification decrease. In this study, fortification scenarios for those taking 
supplements with 200 μg FA in addition to the five voluntary products and dietary 
folate show that 99% of children aged 4 years and 75% aged 13 years received total 
folate over UL. The fact that some of the supplements designed for children contain 
200 μg FA can be questioned, especial if Norway goes for mandatory fortification but 
also with regards to voluntary fortification. It might be a good decision to limit the 
content of FA in supplements designed for children.  
5.5 The complex mixture of micronutrients 
Low consumption of fruits and vegetables has been consistently related to an 
increased risk of a number of diseases (14;52;140;141). Many components of fruits 
and vegetables may be responsible for the reduced risk. Evidence that a high intake of 
vegetable and fruits reduces health-risk has led to attempts to isolate specific nutrients 
and administer them as supplements, sometimes in very high doses. Most of these 
attempts have been unsuccessful in reducing the precursors or preventing diseases 
and even in some cases have had adverse effects (142;143). The complex mixture of 
micronutrients found in a diet high in fruit and vegetables may be more effective than 
large supplemental doses of a small number of specific micronutrients. It could be 
that several of these compounds work together, but have no effect individually, or 
that other dietary components may be effectors of micronutrient action (144). 
Randomized intervention trials of micronutrient supplements have, to date, largely 
failed to show an improvement in clinical end points. Studies concentrating on whole 
foods or diet pattern may be more effective in demonstrating an effect on clinical end 
points. As mentioned earlier, Larsson et al. reported an inverse association between 
intake of folate from foods and the risk of cancer (55). But they didn’t see the same 
association between supplemental folic acid intake and cancer risk, this have been 
confirmed in other studies (56;57) and by a recent meta-analysis (52). So to reduce 
the incidence of diseases like cancer and CHD, the best advice presently is to 
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consume nutrients through food sources rather than supplements. But it is not 
realistic, at the present time, to advice women to meet the additional 400 μg per day 
target by increasing their intake of folate rich foods, because it will take a long time 
to make such a change, and it may be difficult for all women to achieve a sufficient 
intake 
Kim and colleagues have shown that the dose and timing of folate interventions may 
be critical. Modest doses of FA supplementation suppressed the development and 
progression of colorectal cancer (80;145). These studies show that the interventions 
are critical in providing safe and effective chemoprevention. In this regard, it is 
noteworthy that folate antagonists are used in cancer treatments. It is, therefore, 
theoretically possible that high intakes of supplemental FA, which is more 
bioavailable than folate from foods, may promote the progression of cancer in 
individuals with already existing, undiagnosed cancer (55). 
It is now beyond doubt that folate has a key role in homocysteine metabolism, and 
that high plasma Hcy concentrations can be lowered by FA supplementation or food 
folates. In the NORVIT study there was a reduction in Hcy in those treated with 
folate and B12, but no effect on myocardial events was seen (48). In the HOPE-2 
study, despite a reduction in Hcy, again vitamin treatment had no effect on 
myocardial events (146). It seems therefore clear that FA does not reduce the risk of 
atherosclerosis by reducing Hcy, even if folate intake is an important predictor of 
plasma Hcy. This is a parallel to The Alpha-Tocopherol, Beta Carotene Cancer 
Prevention Study in 1994. By the early 1990s, there was mounting clinical 
epidemiologic evidence of reduced cancer risk associated with increased intake of 
antioxidants. Treatment with vitamin E and beta-carotene were considered unlikely to 
be harmful and likely to be helpful, and the question was asked whether antioxidants 
could reduce lung cancer in high risk groups like smokers. No benefit was seen with 
either therapy, but compared to placebo a disturbing worsening trend was seen in the 
beta-carotene-treated group (142). We have to see in a larger perspective, and sort out 
the right marker. Folate is not the only factor that correlates with elevated Hcy 
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concentrations, it can also be the result of low intakes of vitamin B12, poor kidney 
function, smoking, coffee consumption, high body weight or mutations in the folate-
metabolizing enzymes (147). A high tHcy concentration may just be a marker of low 
vitamin status, or an unhealthy lifestyle rather than a true causal risk factor. The 
relation between intermediates in the Hcy pathway and health-risk is therefore 
complex and requires many further studies. 
A common variant of the MTHFR gene has been identified with a change of a 
cytosine to a thymine at nucleotide 677, and this variant is associated with reduced 
enzyme activity. The TT genotype is associated with an increased risk of having a 
child with a neural tube defect (148) and is a risk factor for some types of cancers 
(52). The modulation in human health risk between MTHFR genotypes can be 
accentuated by low folate status (149;150). The MTHFR 677TT genotype also affect 
the sensitivity of patients to folate based chemotherapeutic cancer treatments (151). 
The foetus is not only risking NTDs. The MTHFR TT genotype of the mother has 
been shown to increase the risk of Down’s syndrome especially if the folate status in 
the preconception period is low (150). 
Genetic variation certainly has an important influence on human nutritional 
requirements. New knowledge of the complexity of the interaction between genes 
and diet offered opportunities to recommended optimal nutrition for individuals in the 
future. In the meantime it is important to be humble and have courage to admit there 
is much we don’t know yet. 
5.6 Unanswered questions 
We need answers to what will happen if we go for mandatory fortification -before we 
start a program.  
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We have to know more about the folate status in the population 
A number of questions regarding the bioavailability of natural and added folates and 
the level of folate intake from dietary sources needed to meet nutritional requirements 
remain unanswered. Much more research is also needed to characterise better markers 
of micronutrient status both in terms of metabolic effects and health effects, so that 
risk persons can be identified and supplementation modified accordingly. It might be 
that a complex lifelong behaviour pattern needs to be studied before conclusions can 
be made regarding folate and disease. 
How many will exeed UL? 
In this study the children aged 4 years old, was the most vulnerable group. Even 
though it is not allowed to fortify food for small children in Norway, they will 
nevertheless get a higher intake of FA if mandatory fortification is implemented. 
After FA fortification started in US it is the children less than 5 years who have the 
highest serum folate concentration in the US population (68). 
I did not consider children less than 4 years in my dietary modelling. This is because 
The Norwegian Food Safety Authority defined them as an own category, and don’t 
include them in the model of fortification. The UL for children 1–3 years is 200 
μg/day, which is much lower than that for adults, the risk of exceeding the upper limit 
in this group may be greater. In Spedkost and småbarnskost, nationwide surveys of 
Norwegian children aged 6, 12 and 24 month, it has been reported that the two years 
old children (n=1720) had an intake of 95g bread/day, witch means they are risking a 
high intake of FA in case of fortification. In the US, Lewis et al estimated that 15–
25% of children aged one to eight years had FA intakes exceeding their UL under the 
current US fortification program (114). 
Although the women capable of becoming pregnant are the target group, some of 
them are also risking an intake over UL. Information from the database of the 
Spanish Collaborative Study of Congenital Malformations (152), reveals that, in 
2004, more than 60% of women of healthy children who had been using FA 
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supplement since before the present pregnancy had ingested higher doses than 
recommended. The proportion using more than 1 mg was 63%. The same results 
were seen in women who started to take FA supplements after becoming pregnant 
(152). This is perhaps one of the biggest problems, it is common that the people who 
eat most supplements also are the one who eat and live most healthy. If they in 
addition have opportunity to choose voluntary fortified products it is not unrealistic to 
suppose they will choose them too. 
If the pregnant women use too much FA it can also affect the foetus. Recently a study 
from Ireland of 11 infants showed that all exhibited unmetabolised FA in their cord 
blood. None of the mothers were consuming FA supplements. The levels of 
unmetabolised folic acid detected in the cord blood must therefore be due to recent 
dietary intake of FA from commercially available fortified foods on the Irish market 
(153). It is unknown if the presence of FA in cord blood will imply any risk, but the 
likelihood is that the longer the exposure the more likely the potential for harm. 
Monitoring 
Monitoring is very important, not only both of the industries production and labelling 
but also of the folat/folic acid status in the population. 
We need clear instructions before it is possible to start a mandatory fortification. It is 
important that the product don’t contain more than it has been permitted to contain. If 
Norway goes for mandatory fortification, voluntary fortification with FA will not be 
permitted, then we also need monitoring to ensure that import products have not been 
fortified of mistake, because most of the states Norway imports from have voluntary 
fortification. Most of all we need a monitoring plan to identify adverse health effects 
in time. 
The labelling issue needs also to be considered. If the wheat flour will be fortified, 
products like cakes, hamburger bead and pizza will also be fortified. What happen if 
new EU regulations forbid a claim for fortification to be made, for example if the 
product is deemed to be too high in fat, salt or sugar? EU will probably forbid health 
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claims on that type of foods, but fortification in all foods made from fortified flour 
will have to be declared. 
 65
6. Conclusion 
In NNR 2004 the UL for folate is only valid for FA not dietary folate. There is a very 
small risk to get a FA intake above the UL. If the FA intake is in addition to the 
dietary folate the risk is much higher. The most vulnerable group would be the 
youngest children. 
It is clear that the relationships between folate and health outcomes are complex; 
further, we need a better understanding of the relevant biological mechanisms to 
avoid misinterpretation. And we need to know more about the effects of chronic 
exposure to FA before instituting mandatory fortification. It is important that medical 
doctors and other health care providers continue to encourage women of child-
bearing age to increase folate intakes from foods and dietary supplements whether 
mandatory fortification proceeds or not. 
In the late 1990`s when US started the mandatory fortification, the optimism was 
high that FA didn’t just promote NTD but had a lot of benefits for the whole 
population. To day it is more uncertainty, the only thing we know for certain is that 
FA promote 50-70%of the NTDs. In Norway it will say at best less than 50 cases a 
year. 
If it is unlikely that any fortification level would prevent all of the preventable NTD, 
is it then ethical to expose the whole population without choice, for FA? We need to 
ask the right questions and undertake appropriate research. It is quite likely that there 
will be no adverse effects from chronic, even a lifetime exposure to FA, but we do 
not know this for certain. For that reason, we have to wait with mandatory 
fortification. 
Each day scientists discover new genes sequences. As the interactions between 
genetic variation and nutritional requirements become more studied, it will allow 
dietary recommendations to be individualised according to genotype to ultimately 
reduce our risk of a lot of diseases and increase health. Meanwhile, we can 
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recommend consuming a well-balanced diet with a variety of foodstuffs, be 
physically active, maintain a normal body weight, avoid smoking and drink less 
alcohol. This will benefit the whole population. 
Most of all we need to be humble and always have in mind that we do not have all the 
answers about the mystery of life. 
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Appendix 1 
Calculation 
JUICE 
• 100 g Juice 43kcal 
• 100kcal (100/43 =2,3259g/kcal)  2,3259*100=232,59g/100kcal 
• 100kcal  20mcg  (20 / 232,59 =0,086 mcg/g) 
• 8,6 mcg /100 g juice 
• 9 mcg 
 
NEKCTAR 
• 100g  42kcal 
• 100/42 *100 = 238 g/100kal 
• 20/238  = 0,084 mcg/g 
• 8,4 mcg/100g 
• 8 mcg 
 
YOGHURT 
• 100g natural: 79kcal 
• 100kcal ((100/79)*100)= 126,58g 
• 20mcg/100kcal = 20/126,58g (=0,158 mcg/g) 
• 15,8mcg/100g 
• 16 mcg 
BREAKFAST CERIALS UNSWEETED 
• 100 g  345 kcal 
• 100/345 *100 = 28,99g 
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• 20 mcg / 100kca = 20mcg / 28,99g (= 0,69 mcg/g) 
• 69 mcg / 100g 
 
BREAKFAST CERIALS SWEETED 
• 100 g  385kcal 
• 100/385 * 100 = 25,97g 
• 20 mcg/ 100kcal = 20mcg/25,97 g ( 0,77) 
• 77 mcg / 100g 
 
H-MILK 
• 100g  66kcal 
• 100/66*100=151,515 
• 20 mcg/100 kcal = 20/151,515g (0,132) 
• 13 mcg / 100g 
 
MILK 1,5% Fatt 
• 100g  46 kcal 
• 100/46*100=217,391 
• 20mcg/100 kcal=20/217,391 (0,092) 
• 9 mcg/100 g 
 
MILK 0,7 % fatt 
• 100g  38 kcal 
• 100/38*100=263,158 
• 20mcg/100 kcal=20/263,158 (0,076) 
• 8 mcg/100g 
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MILK 0,1% Fatt 
• 100g  33 kcal 
• 100/33*100=303,03 
• 20mcg/100kcal=20/303,03 (0,066) 
• 7mcg/100g 
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Appendix 2 
The Norwegian Mother and Child Cohort Study (MoBa) 
Pregnant women are recruited to the study through a postal invitation after they have 
signed up for the routine ultrasound examination in their local hospital. At the 
ultrasound examination, participating women and their partners donate biological 
samples. After birth, a blood sample from the umbilical vein is collected and a second 
blood sample is taken from the mother. Participants are asked to provide biological 
samples and to answer questionnaires covering a wide range of information up to age 
7 for the child. The cohort is linked to national health registries to include certain 
outcomes. The study has been approved by the regional committee for ethics in 
medical research and the Data Inspectorate. The sample used here includes 19.711 
pregnancies using version 1 of the quality-assured data files made available for 
research in 2005. 
 
